Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 17 of 17 entries
View as:

Comparative Study of PK and BE of VM-1500FDC (Fixed-dose Combination) and Elpida® With Truvada® сo-administrated 1 Daily Fasting in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03706924 Org: User:
Start: 06/01/18 End: 10/12/18 Due: 10/12/19

Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

Phase: N/A Priority: Normal
NCT ID: NCT03706898 Org: User:
Start: 10/01/18 End: 04/10/19 Due: 04/10/20

Clinical Trial of Safety and Pharmacokinetics of VM-1500 After Multiple Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02489435 Org: User:
Start: 07/31/12 End: 06/30/13 Due: 06/30/14

Pharmacokinetics Study to Evaluate Drug-Drug Interactions and Safety of Elpida® in Co-Administration With Other Drugs

Phase: N/A Priority: Normal
NCT ID: NCT03709355 Org: User:
Start: 11/14/18 End: 09/06/19 Due: 09/06/20

Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05204121 Org: User:
Start: 12/18/18 End: 04/02/19 Due: 04/02/20

Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza

Phase: N/A Priority: Normal
NCT ID: NCT05093998 Org: User:
Start: 01/15/22 End: 07/31/23 Due: 07/31/24

Dose Range Study to Evaluate the Efficacy and Safety of AV5080 in Patients With Influenza

Phase: N/A Priority: Normal
NCT ID: NCT05095545 Org: User:
Start: 11/13/17 End: 08/30/19 Due: 08/30/20

Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05165550 Org: User:
Start: 04/12/22 End: 07/13/22 Due: 07/13/23

An Open-label Clinical Study of the Pharmacokinetics and Safety of Elsulfavirine, 200 mg Tablets, With Single and Multiple Oral Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05148754 Org: User:
Start: 01/23/21 End: 08/16/21 Due: 08/16/22

Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05204394 Org: User:
Start: 04/01/22 End: 10/16/23 Due: 10/16/24

Study to Evaluate Safety, Tolerability and Pharmacokinetics of VM-1500A-LAI Single and Multiple Ascending Doses in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03706911 Org: User:
Start: 01/21/19 End: 05/18/20 Due: 05/18/21

Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection

Phase: N/A Priority: Normal
NCT ID: NCT02485509 Org: User:
Start: 03/31/13 End: 12/31/13 Due: 12/31/14

Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500

Phase: N/A Priority: Normal
NCT ID: NCT02489487 Org: User:
Start: 09/30/14 End: 10/31/14 Due: 10/31/15

Efficacy, Safety and Optimal Dose of VM-1500 in Comparison to Efavirenz Added to Standard-of-care Antiretroviral Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02489461 Org: User:
Start: 08/05/14 End: 09/18/17 Due: 09/18/18

Post-approval Observational Study of Elpida® in the First Line Therapy for HIV-1 Infected Patients With Background Standard ART

Phase: N/A Priority: Normal
NCT ID: NCT03706950 Org: User:
Start: 03/15/18 End: 12/31/22 Due: 12/31/23

Open Labelled, Randomized Study to Evaluate the Efficacy, Safety and Dose Selection of VM-1500A-LAI Drug in HIV-infected Patients Transferred From Previous Stable Therapy (NNRTI + 2NRTI), Including ELPIDA®

Phase: N/A Priority: Normal
NCT ID: NCT05163535 Org: User:
Start: 01/19/21 End: 08/03/21 Due: 08/03/22

Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03730311 Org: User:
Start: 05/31/19 End: 12/31/19 Due: 12/31/20